https://orcid.org/0000-0002-2658-7255
Abstract
This study identified an increased risk of lymphoid malignancy in Shwachman-Diamond syndrome (SDS) with an observed risk 38-fold higher than expected based on population data. Increased toxicity was observed with standard therapies in patients with SDS.
References
1.
Nelson
AS
, Myers
KC
. Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome
. Hematol Oncol Clin North Am
. 2018
;32
(4
):687
-700
.2.
Furutani
E
, Liu
S
, Galvin
A
, et al. Hematologic complications with age in Shwachman-Diamond syndrome
. Blood Adv
. 2022
;6
(1
):297
-306
.3.
Myers
KC
, Furutani
E
, Weller
E
, et al. Myelodysplastic syndrome and acute myeloid leukemia in patients with Shwachman Diamond syndrome: a multicentre, retrospective, cohort study
. Lancet Haematol
. 2020
;7
(3
):e238
-e246
.4.
Reilly
CR
, Shimamura
A
. Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances
. Blood
. 2023
;141
(13
):1513
-1523
.5.
Donadieu
J
, Fenneteau
O
, Beaupain
B
, et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome
. Haematologica
. 2012
;97
(9
):1312
-1319
.6.
Dror
Y
, Freedman
MH
. Shwachman-Diamond syndrome
. Br J Haematol
. 2002
;118
(3
):701
-713
.7.
Dror
Y
. Shwachman-Diamond syndrome
. Pediatr Blood Cancer
. 2005
;45
(7
):892
-901
.8.
Bezzerri
V
, Cipolli
M
. Shwachman-Diamond syndrome: molecular mechanisms and current perspectives
. Mol Diagn Ther
. 2019
;23
(2
):281
-290
.9.
Kawashima
N
, Oyarbide
U
, Cipolli
M
, Bezzerri
V
, Corey
SJ
. Shwachman-Diamond syndromes: clinical, genetic, and biochemical insights from the rare variants
. Haematologica
. 2023
;108
(10
):2594
-2605
.10.
Warren
A
. Molecular basis of the human ribosomopathy Shwachman-diamond syndrome
. Adv Biol Regul
. 2018
;67
:109
-127
.11.
Boocock
GR
, Morrison
JA
, Popovic
M
, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome
. Nat Genet
. 2003
;33
(1
):97
-101
.12.
Cesaro
S
, Pegoraro
A
, Sainati
L
, et al. A prospective study of hematologic complications and long-term survival of Italian patients affected by Shwachman-Diamond syndrome
. J Pediatr
. 2020
;219
:196
-201.e1
.13.
SEER∗Explorer
. An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program. National Cancer Institute; 19 April 2023. [updated: 16 November 2023; cited 27 November 2023]
. Accessed 1 December 2023. https://seer.cancer.gov/statistics-network/explorer/. Datasource(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries.14.
Wagle
N
, Berger
MF
, Davis
MJ
, et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing
. Cancer Discov
. 2012
;2
(1
):82
-93
.15.
Kluk
MJ
, Lindsley
RC
, Aster
JC
, et al. Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies
. J Mol Diagn
. 2016
;18
(4
):507
-515
.16.
Morin
RD
, Johnson
NA
, Severson
TM
, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
. Nat Genet
. 2010
;42
(2
):181
-185
.17.
Kennedy
AL
, Myers
KC
, Bowman
J
, et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
. Nat Commun
. 2021
;12
(1
):1334
.18.
Machado
HE
, Øbro
NF
, Williams
N
, et al. Convergent somatic evolution commences in utero in a germline ribosomopathy
. Nat Commun
. 2023
;14
(1
):5092
.19.
LeBlanc
FR
, Grier
DD
, Myers
KC
, Shimamura
A
, Pommert
L
. A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome
. Pediatr Blood Cancer
. 2024
;71
(8
):e31137
.20.
Sharma
A
, Sadimin
E
, Drachtman
R
, Glod
J
. CNS lymphoma in a patient with Shwachman Diamond syndrome
. Pediatr Blood Cancer
. 2014
;61
(3
):564
-566
.21.
Verbrugge
J
, Tulchinsky
M
. Lymphoma in a case of Shwachman-Diamond syndrome: PET/CT findings
. Clin Nucl Med
. 2012
;37
(1
):74
-76
.22.
Lindsley
RC
, Saber
W
, Mar
BG
, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation
. N Engl J Med
. 2017
;376
(6
):536
-547
.23.
Xu-Monette
ZY
, Medeiros
LJ
, Li
Y
, et al. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
. Blood
. 2012
;119
(16
):3668
-3683
.24.
Lohr
JG
, Stojanov
P
, Lawrence
MS
, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
. Proc Natl Acad Sci U S A
. 2012
;109
(10
):3879
-3884
.25.
Magnusson
S
, Gisselsson
D
, Wiebe
T
, Kristoffersson
U
, Borg
Å
, Olsson
H
. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey
. Pediatr Blood Cancer
. 2012
;59
(5
):846
-853
.26.
Ryan
RJH
, Nitta
M
, Borger
D
, et al. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas
. PLoS One
. 2011
;6
(12
):e28585
.© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2025
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal